OptimizeRX (OPRX) Target Cut By 2x the Market Cap at Roth Capital
Tweet Send to a Friend
Roth Capital analyst Richard Baldry lowered the price target on OptimizeRX (NASDAQ: OPRX) to $66.00 (from $112.00) after 1Q21 revenues ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
